RFC
SUPN icon

Russell Frank Company’s Supernus Pharmaceuticals SUPN Stock Holding History

Russell Frank Company’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$8.67M Sell
568,410
-79,867
-12% -$1.04M 0.02% 1038
2015
Q4 		$8.87M Buy
648,277
+338,145
+109% +$5.23M 0.02% 958
2015
Q3 		$4.35M Sell
310,132
-46,126
-13% -$858K 0.01% 1356
2015
Q2 		$6.05M Buy
356,258
+320,125
+886% +$4.56M 0.01% 1304
2015
Q1 		$437K Buy
+36,133
New +$341K ﹤0.01% 2436

Other funds holding SUPN

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
NPIC
Neumeier Poma Investment Counsel Carmel, California $1.21B AUM 70.48% 1-Year Est. Return

Russell Frank Company's SUPN Position: Q1 2016 in Review

Russell Frank Company reduced its Supernus Pharmaceuticals (SUPN) stake by 12% in Q1 2016, selling an estimated $1.04M and leaving 568,410 shares worth $8.67M. The position accounts for 0.02% of the portfolio, ranked #1038.

Russell Frank Company first reported a position in SUPN in Q1 2015 and has held it in 5 quarters since. The position peaked at $8.87M in Q4 2015. 213 funds tracked by Wall St. Rank hold SUPN as of Q1 2016.

  • Russell Frank Company held 568,410 shares of Supernus Pharmaceuticals worth $8.67M as of Q1 2016.
  • Russell Frank Company sold 79,867 Supernus Pharmaceuticals shares in Q1 2016, an estimated $1.04M.
  • Supernus Pharmaceuticals made up 0.02% of Russell Frank Company's portfolio in Q1 2016, its #1038 holding.
  • Russell Frank Company first reported a position in Supernus Pharmaceuticals in Q1 2015 and has held it in 5 quarters since.
  • Russell Frank Company's Supernus Pharmaceuticals position peaked at $8.87M in Q4 2015.
  • 213 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.